← All indications
Neutropenia
A decrease in the number of NEUTROPHILS found in the blood.
Subtype terms (1)
More specific conditions that are subtypes of Neutropenia in the MeSH hierarchy.
- Febrile Neutropenia
43 drugs (34 approved, 9 experimental)
Drugs by status
Approved for this indication (4)
Phase 4 trials (9)
Phase 3 trials (42)
- levofloxacin
- tioguanine
- Mavorixafor
- plerixafor
- amsacrine
- urea
- procaine benzylpenicillin
- bone autograft
- busulfan
- ceftobiprole
- clavulanate
- doxorubicin
- ethanol
- fluorouracil
- idarubicin
- caspofungin
- leucovorin
- lithium
- anidulafungin
- carmustine
- allogeneic hematopoietic stem cells
- eflapegrastim
- cyclophosphamide
- stem cells
- daunorubicin
- bevacizumab
- alemtuzumab
- fluconazole
- Anti-thymocyte Globulin (Rabbit)
- vancomycin
- +12 more
Phase 2 trials (40)
- decitabine
- methylprednisolone
- mercaptopurine
- amifostine
- darbepoetin alfa
- bifidobacterium animalis
- cd3,cd19 depleted hematopoietic stem cells
- astragalus membranaceus
- clt-008
- danggui buxue
- prednisone
- eravacycline
- tacrolimus
- naltrexone
- epirubicin
- daptomycin
- inulin
- isavuconazonium
- leridistim
- luspatercept
- vincristine
- ifosfamide
- mannose binding lectin
- sirolimus
- cyclosporine
- mycophenolate
- angiotensin 1-7
- topotecan
- autologous platelets
- autologous umbilical cord blood
- +10 more
Phase 1 trials (14)
Organizations
Organization Involved with Phase 4 Indications (51)
- Mayne Pharma
- Amgen
- Sandoz
- Astellas
- Gilead Sciences
- Schering-Plough
- Merck
- Sanofi
- Dong-A Pharmaceutical
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Anglo Celtic Cooperative Oncology Group
- Charing Cross Hospital
- Cornell University
- Harvard University
- Michigan State University
- Minsk State Clinical Hospital No 9
- Osaka University
- Shandong Provincial Hospital
- Scottish Cancer Therapy Network
- Sykehuset Innlandet HF
- Sorlandet Hospital HF
- The Hospital of Vestfold
- University of Oslo
- University of Ottawa
- Peking University
- Prince of Songkla University
- Tel Aviv University
- University of Ulsan
- +21 more
Organization Involved with Phase 3 Indications (85)
- Symyoo
- Spectrum Pharmaceuticals
- Basilea Pharmaceutica
- Green Cross Corporation
- Merckle
- Pfizer
- Mylan
- Bayer
- BeyondSpring Pharmaceuticals Inc.
- Biocad
- Cubist
- Eurofarma Laboratorios S.A.
- Gema Biotech S.A.
- GlaxoSmithKline
- Hengrui Therapeutics, Inc.
- Shantha Biotechnics Limited
- Teva
- Generon (Shanghai) Corporation Ltd.
- Medical Research Council
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Marrow Donor Program
- University of Roma La Sapienza
- Huazhong University of Science and Technology
- University of Pennsylvania
- Maastricht University
- University of Pittsburgh
- Puget Sound Blood Center
- Emory University
- University of Washington
- +55 more
Organization Involved with Phase 2 Indications (73)
- Synageva Biopharma
- Forest Laboratories
- Allergan
- BioLab 612 LLC
- Cellerant Therapeutics
- Cleveland BioLabs
- Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
- Kyowa Hakko Kirin
- Myelo Therapeutics GmbH
- Parexel
- PhytoHealth Corporation
- Prolong Pharmaceuticals
- S&D Pharma SK s.r.o.
- Constant Pharmaceuticals
- Telik
- Xiamen Amoytop Biotech Co., Ltd.
- National Polytechnic Institute, Mexico
- Slovak Academy of Sciences
- California Cancer Assocaties for Research & Excellence
- Federation Francophone de Cancerologie Digestive
- Guangzhou Medical University
- Jilin University
- McGill University
- Nanjing Medical University
- Oregon Health and Science University
- Radboud University
- Qingdao University
- Sanquin
- Southwest Oncology Group
- University of Florida
- +43 more
Organization Involved with Phase 1 Indications (16)
- Celgene
- Enzon
- Amplyx Pharmaceuticals
- Jiangsu T-Mab Biopharma Co.,Ltd
- X4 Pharmaceuticals
- Canadian Cancer Trials Group
- Gynecologic Oncology Group
- Northwestern University
- University of Toronto
- Mayo Clinic
- University of Chicago
- University of Cologne
- Unidade Integrada de Farmacologia e Gastroenterologia
- Wake Research Associates
- Tianjin Medical University
- University of North Carolina at Chapel Hill
Organization Involved with Other Experimental Indications (11)
- Hebei University
- Federal University of Minas Gerais
- Hospital Juarez de Mexico
- Postgraduate Institute of Medical Education and Research
- Thomas Jefferson University
- Federal University of Rio de Janeiro
- University of Freiburg
- Catholic University of Korea
- University of Sao Paulo
- KhonKaen University
- National Research Council of Thailand